Staar Surgical reported $17.23M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Atrion ATRI:US 28.05M 5.13M
Boston Scientific BSX:US $ 1022M 55M
Cerus CERS:US $ 19.72M 1.64M
Cooper Companies COO:US $ 291.3M 6M
Exact Sciences EXAS:US $ 144.6M 9.9M
Hologic HOLX:US $ 443.7M 45.4M
Johnson & Johnson JNJ:US $ 7919M 321M
Meridian Bioscience VIVO:US $ 31.04M 11.71M
Merit Medical Systems MMSI:US $ 159.91M 5.4M
Novartis NOVN:VX SF 3749M 6M
Orasure Technologies OSUR:US $ 52.65M 9.21M
Orthofix International OFIX:US $ 31.6M 3.28M
Rockwell Medical RMTI:US $ 16.94M 0.03M
Sientra SIEN:US $ 8.77M 218K
Staar Surgical STAA:US $ 17.23M 3.29M
Valeant Pharmaceuticals VRX:CN $ 742.71M 191.71M